a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are through the diet, where patients are instructed ind reducing their daily intake of phosphate. But since phosphate exists in both organic and inorganic forms in the diet, this leads to several problems. Informations of the bioavability and furthermore the effect of plasma koncentrations of phosphate are lacking for both forms of phosphate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis

NCT00119990

Peritoneal Dialysis

TERMINATED NA

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

NCT02488200

End Stage Renal Disease

UNKNOWN

Dietary Therapy in Dialysis Patients

NCT04505462

End Stage Renal Disease on Dialysis

COMPLETED NA

Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions

NCT00633308

Kidney Failure

WITHDRAWN PHASE2

Aerobic Exercise During Hemodialysis

NCT01912417

Kidney Failure, Chronic

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease Requiring Chronic Dialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phosphate modified diet with organic phosphate

Group Type EXPERIMENTAL

Diet containing organic phosphate

Intervention Type OTHER

The patients will be receiving a 5 days diet containing organic phosphate

Phosphate modified diet with inorganic phosphate

Group Type EXPERIMENTAL

Diet containing inorganic phosphate

Intervention Type OTHER

The patients will be receiving a 5 days diet containing inorganic phosphate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet containing organic phosphate

The patients will be receiving a 5 days diet containing organic phosphate

Intervention Type OTHER

Diet containing inorganic phosphate

The patients will be receiving a 5 days diet containing inorganic phosphate

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> 18 years
* Competent
* The patient should be able to take a sample of p-fluid and urine by himself
* Chronic peritoneal dialysis
* Reads and understand danish
* Has been informed written and oraly about the study and signed informed consent
* P-phosphate koncentrations 0,7-2,0 .mol/l
* P - ioniset calcium 1,1-1,4 mmol/l